Greten T - Search Results

1

Plentz RR, Bitzer M, Greten T, Nadalin S, Vogel A. Plentz RR, et al. Among authors: greten t. Visc Med. 2016 Dec;32(6):431-433. doi: 10.1159/000450720. Epub 2016 Nov 18. Visc Med. 2016. PMID: 28229079 Free PMC article. No abstract available.

2

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.

von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismüller TJ, Wedemeyer H, Manns MP, Greten TF, Malek NP. von Hahn T, et al. Among authors: greten tf. Scand J Gastroenterol. 2011 Sep;46(9):1092-8. doi: 10.3109/00365521.2011.589472. Epub 2011 Jun 22. Scand J Gastroenterol. 2011. PMID: 21692710

3

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.

Eggert T, Greten TF. Eggert T, et al. Among authors: greten tf. Digestion. 2017;96(1):1-4. doi: 10.1159/000464282. Epub 2017 Jun 13. Digestion. 2017. PMID: 28605745 Free PMC article. Review.

4

CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.

Diggs LP, Ruf B, Ma C, Heinrich B, Cui L, Zhang Q, McVey JC, Wabitsch S, Heinrich S, Rosato U, Lai W, Subramanyam V, Longerich T, Loosen SH, Luedde T, Neumann UP, Desar S, Kleiner D, Gores G, Wang XW, Greten TF. Diggs LP, et al. Among authors: greten tf. J Hepatol. 2021 May;74(5):1145-1154. doi: 10.1016/j.jhep.2020.11.037. Epub 2020 Dec 1. J Hepatol. 2021. PMID: 33276030 Free PMC article.

5

Immunology and immunotherapy of cholangiocarcinoma.

Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, Wang XW. Greten TF, et al. Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):349-365. doi: 10.1038/s41575-022-00741-4. Epub 2023 Jan 25. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36697706 Review.

6

Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Ma L, Wang L, Khatib SA, Chang CW, Heinrich S, Dominguez DA, Forgues M, Candia J, Hernandez MO, Kelly M, Zhao Y, Tran B, Hernandez JM, Davis JL, Kleiner DE, Wood BJ, Greten TF, Wang XW. Ma L, et al. J Hepatol. 2021 Dec;75(6):1397-1408. doi: 10.1016/j.jhep.2021.06.028. Epub 2021 Jun 30. J Hepatol. 2021. PMID: 34216724 Free PMC article.

7

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Greten TF, et al. J Immunol Methods. 2002 Dec 20;271(1-2):125-35. doi: 10.1016/s0022-1759(02)00346-0. J Immunol Methods. 2002. PMID: 12445736

8

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.

Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF. Scheffer SR, et al. Int J Cancer. 2003 Jan 10;103(2):205-11. doi: 10.1002/ijc.10777. Int J Cancer. 2003. PMID: 12455034 Free article.

9

CD40 in hepatocellular carcinoma: relevant or not?

Greten TF, Ott M. Greten TF, et al. Eur J Gastroenterol Hepatol. 2003 Feb;15(2):113-4. doi: 10.1097/00042737-200302000-00001. Eur J Gastroenterol Hepatol. 2003. PMID: 12560752

10

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Korangy F, et al. Clin Cancer Res. 2004 Jul 1;10(13):4332-41. doi: 10.1158/1078-0432.CCR-04-0181. Clin Cancer Res. 2004. PMID: 15240519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page